Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

       
Total article views   HTML views PDF downloads Totals
11,237 Dovepress* 10,020+ 2,084 12,104
PubMed Central* 1,217 422 1,639
Totals 11,237 2,506 13,743
*Since 6 December 2012
+Since July 2016

View citations on PubMed and Google Scholar